Upcoming Stock Splits This Week (August 4 to August 8): A Guide to Stock Split Strategies
ByAinvest
Sunday, Aug 3, 2025 9:41 pm ET1min read
ANGH--
United Therapeutics Corp. (UTHR) also announced a significant stock buyback. The company entered into two Accelerated Share Repurchase (ASR) agreements with Citibank, N.A. (Citi) to repurchase an aggregate $1 billion of UTHR common stock. This move is expected to boost shareholder value by reducing the number of outstanding shares [1].
Rigetti Computing (RGTI), a prominent player in the quantum computing sector, has seen its stock price soar over the past year. While it is not expected to undergo a stock split in the near future, the company's stock has been volatile. Rigetti's board of directors approved a reverse stock split last year but never conducted one. The company's stock price has since risen to $15, making it less likely to need a reverse stock split to meet Nasdaq compliance requirements [2].
In summary, the upcoming stock splits are part of strategic moves by companies to either regain compliance with stock exchange rules or make their stocks more accessible to a broader range of investors. United Therapeutics' stock buyback is also a significant event, aiming to enhance shareholder value.
References:
[1] https://www.nasdaq.com/articles/united-therapeutics-launches-1-bln-stock-buyback
[2] https://www.nasdaq.com/articles/stock-split-watch-rigetti-computing-next
AQMS--
FLGC--
NIVF--
RGTI--
Several companies are set to undergo stock splits in the week of August 4 to August 8. NewGenIVF Group, Anghami Inc., Aqua Metals, and Flora Growth will all undergo reverse stock splits to regain Nasdaq listing requirements or meet minimum bid price requirements. The splits are intended to lower the price per share and make the stock more accessible to investors. The main idea is to appeal to a broader investor base or stay compliant with stock exchange rules.
Several companies are set to undergo stock splits in the week of August 4 to August 8. These companies include NewGenIVF Group, Anghami Inc., Aqua Metals, and Flora Growth. The primary reasons for these splits are to regain Nasdaq listing requirements or meet minimum bid price requirements. The main objective is to lower the price per share and make the stock more accessible to a broader investor base or to comply with stock exchange rules.United Therapeutics Corp. (UTHR) also announced a significant stock buyback. The company entered into two Accelerated Share Repurchase (ASR) agreements with Citibank, N.A. (Citi) to repurchase an aggregate $1 billion of UTHR common stock. This move is expected to boost shareholder value by reducing the number of outstanding shares [1].
Rigetti Computing (RGTI), a prominent player in the quantum computing sector, has seen its stock price soar over the past year. While it is not expected to undergo a stock split in the near future, the company's stock has been volatile. Rigetti's board of directors approved a reverse stock split last year but never conducted one. The company's stock price has since risen to $15, making it less likely to need a reverse stock split to meet Nasdaq compliance requirements [2].
In summary, the upcoming stock splits are part of strategic moves by companies to either regain compliance with stock exchange rules or make their stocks more accessible to a broader range of investors. United Therapeutics' stock buyback is also a significant event, aiming to enhance shareholder value.
References:
[1] https://www.nasdaq.com/articles/united-therapeutics-launches-1-bln-stock-buyback
[2] https://www.nasdaq.com/articles/stock-split-watch-rigetti-computing-next

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet